MOG and myeloid sarcoma: Upon re-evaluation, 11 of 25 (44%) of these patients were found to be myelin oligodendrocyte glycoprotein (MOG) antibody positive, 4 of the remaining 14 patients did not meet 2017 McDonald criteria for MS, and of the 10 remaining patients who did meet 2017 McDonald criteria for MS had clinical features that were unusual for an MS diagnosis (29).